Table 1.
Demographics and Clinical Characteristics of HLS.
| Clinical Characteristics | HLS (n = 12) | CON (n = 36) |
|---|---|---|
| Female sex, n (%) | 7 (58.33%) | 21 (58.33%) |
| Ethnicity, n (%) | ||
| White | 3 (25%) | 20 (55.6%) |
| Black | 4 (33%) | 1 (2.8%) |
| Pardo | 5 (42%) | 15 (41.7%) |
| Presence of B symptoms, n (%) | 7 (58.33%) | — |
| First lymph node appearance, n (%) | ||
| Mediastinum | 6 (50%) | — |
| Neck | 5 (41.67%) | — |
| Groin | 1 (8.33%) | — |
| Sessions of CT (mean ± SD) | 11.80 ± 4.66 | — |
| Sessions of RT (mean ± SD) | 12.00 ± 10.79 | — |
| Years from diagnosis (mean ± SD) | 4.80 ± 3.54 | — |
| Age at diagnosis (mean ± SD) | 26.50 ± 6.31 | — |
| Level of physical activity, n (%) | ||
| Low levels | 2 (16.67%) | 6 (16.67%) |
| Moderate levels | 3 (25%) | 9 (25%) |
| High levels | 7 (58.33%) | 21 (58.33%) |
Abbreviations: HLS, Hodgkin’s lymphoma survivors; CON, control group; SD, standard deviation; CT, chemotherapy; RT, radiotherapy.